INTEGRA LIFESCIENCES HOLDINGS CORP Current State and Local Tax Expense (Benefit)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Current State and Local Tax Expense (Benefit) of $1.49 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP current state and local tax expense (benefit) for the quarter ending 2013-03-31 was $400.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP current state and local tax expense (benefit) for the quarter ending 2012-12-31 was $1.17M.
- INTEGRA LIFESCIENCES HOLDINGS CORP current state and local tax expense (benefit) for the quarter ending 2012-09-30 was $200.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP current state and local tax expense (benefit) for fiscal 2025 was $1.49M, a 11.95% increase from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP current state and local tax expense (benefit) for fiscal 2024 was $1.33M, a 53.35% decline from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP current state and local tax expense (benefit) for fiscal 2023 was $2.85M, a 25.66% decline from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP current state and local tax expense (benefit) for fiscal 2022 was $3.83M, a 66.29% decline from fiscal 2021.
| Period end | Current State and Local Tax Expense (Benefit) 3 month | Current State and Local Tax Expense (Benefit) 6 month | Current State and Local Tax Expense (Benefit) 9 month | Current State and Local Tax Expense (Benefit) 12 month | Current State and Local Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $1.49M 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | $1.33M 10-K · filed 2026-02-26 | ||||
| 2023-12-31 | $2.85M 10-K · filed 2026-02-26 | ||||
| 2022-12-31 | $3.83M 10-K · filed 2025-02-25 | ||||
| 2021-12-31 | $11.38M 10-K · filed 2024-02-28 | ||||
| 2020-12-31 | $5.03M 10-K · filed 2023-02-22 | ||||
| 2019-12-31 | $3.45M 10-K · filed 2022-02-24 | ||||
| 2018-12-31 | $1.61M 10-K · filed 2021-02-23 | ||||
| 2017-12-31 | $1.23M 10-K · filed 2020-02-21 | ||||
| 2016-12-31 | $2.50M 10-K · filed 2019-02-26 | ||||
| 2015-12-31 | $2.30M 10-K · filed 2018-03-01 | ||||
| 2014-12-31 | $2.12M 10-K · filed 2017-02-23 | $1.68M 10-K · filed 2015-02-27 | |||
| 2013-12-31 | $399.00K 10-K · filed 2016-02-26 | -$1.36M 10-K · filed 2014-02-27 | |||
| 2013-03-31 | $400.00K 10-Q · filed 2014-05-01 | $1.57M derived: sum of 2 quarters · filed 2015-02-27 | $1.77M derived: sum of 3 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $1.37M derived: sum of 2 quarters · filed 2015-02-27 | $1.37M 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $200.00K 10-Q · filed 2012-10-24 | $200.00K 10-Q · filed 2012-10-24 | |||
| 2011-12-31 | -$1.53M 8-K · filed 2014-06-20 | ||||
| 2010-12-31 | $1.14M 10-K · filed 2013-02-26 | ||||
| 2009-12-31 | $4.02M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |